Alert: Rating Upgrade (8/5/22)-Collegium Pharmaceutical Inc (NASDAQ: COLL).


Stock Rating Upgrade

Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Collegium Pharmaceutical Inc (NASDAQ: COLL) rose significantly recently. COLL’s current Value Trend Rating is A and the prior Rating was C. Details supporting this higher rating are included in our next report.


Recent Price Action

Collegium Pharmaceutical Inc (NASDAQ: COLL) stock enjoyed a very large increase of 8.6% on 8/5/22. The shares closed at $20.10. Moreover, unusually high trading volume at 189% of normal accompanied the advance. The stock has been strong relative to the market over the last nine months and has risen 15.5% during the last week.

Current PriceTarget Research Rating

COLL’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.

COLL has a current Value Trend Rating of A (Highest Rating). This VT Rating rose significantly in recent days from C previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. COLL has a neutral Power Rating of 59 but a very high Appreciation Score of 98, producing the Highest Value Trend Rating.

About John Lafferty 118563 Articles
During his career, John has developed valuation and stock rating methodologies, managed institutional portfolios and mutual funds, and provided equity research to institutional investors on thousands of companies. He has been Director of Research at PTR since its inception in 2004.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.